The Food and Drug Administration (FDA) will hold a webinar at 10 a.m. (PT) on Oct. 31 to discuss its proposed rule for laboratory developed tests (LDTs).
This content is restricted to members.
The Food and Drug Administration (FDA) will hold a webinar at 10 a.m. (PT) on Oct. 31 to discuss its proposed rule for laboratory developed tests (LDTs).
This content is restricted to members.
